# 1. Financial Performance ## A. Key Figures * **Revenue:** **₹470 Cr** consolidated (+23%) · **₹272 Cr** stand-alone (+16%) [Q3 FY'26] * **9M Revenue:** **₹1,418.2 Cr** consolidated (+16%) · **₹839 Cr** stand-alone (+13%) * Adjusted PAT: ₹1.7 Cr consolidated · ₹1.3 Cr stand-alone [Q3 FY'26] * **9M Adjusted PAT:** **₹25.2 Cr** consolidated · **₹31 Cr** stand-alone * **EBITDA:** **₹25 Cr** consolidated (+27%) · **₹18 Cr** stand-alone [Q3 FY'26] ## B. Revenue Growth * **Robust Top-Line Momentum:** Strong double-digit revenue growth in Q3 and 9M driven by resilient domestic demand and operating scale. * **Profitability Impact:** Adjusted PAT moderated by **₹8 Cr** exceptional charge from new labor code implementation, affecting both entities.[C] ## C. EBITDA Margins * **Margin Pressure in Quarter:** EBITDA margins declined YoY due to **unfavorable product mix**, **higher employee costs**, and **increased business development spending**.[B] * **Structural Margin Floor:** Management reaffirms **minimum 12% standalone EBITDA margin** commitment for India business, with expectation of **double-digit floor** despite near-term volatility. * **Performance Context:** 9M standalone EBITDA margin of **11%** remains competitive and **in line with industry peers**, despite quarterly softness. ## D. Balance Sheet * **Strong Liquidity Position:** Consolidated cash and equivalents of **₹123 Cr** significantly exceed debt of **₹5 Cr**, indicating robust financial flexibility as of Dec-2025. --- # 2. Domestic & Export Mix ## A. Key Figures * **India Revenue:** **₹648 Cr** 9M FY'26 (+25%) · **78%** of stand-alone revenue (vs. 71% prior year) * **US Revenue Growth:** **+37%** YoY in Q3 FY'26 · **+39%** YoY in Europe * **Export Revenue:** **₹62 Cr** Q3 FY'26 (+13% YoY) · **–12%** in 9M FY'26 ## B. India Revenue * **Core Growth Engine:** India remains the primary driver of expansion, with strong double-digit top-line growth and increasing revenue share, reflecting market share gains and resilient sector-wide demand. * **Pricing Stability:** No significant quarter-on-quarter price changes in domestic markets, supporting volume-led growth momentum. * **Strategic Focus Intensifies:** Revenue mix shift toward India underscores deliberate prioritization of domestic market opportunities over exports. ## C. US Performance * **US Recovery Accelerating:** US operations delivered robust revenue growth and sequential profitability improvement, driven by tariff dynamics and pricing, with expectations of sustained but moderating growth. * **Geographic Diversification:** Expansion underway in Middle East and Australia to capture incremental international growth beyond North America. * **Strong Outlook with Profitability Gains:** Management expects continued strong performance in the US, supported by healthy demand trends and operational recovery. ## D. Europe Challenges * **Revenue Rebound Amid Margin Pressure:** European revenues rose sharply year-on-year, but profitability remains constrained by elevated operating costs despite modest regional demand recovery. * **Mixed Operational Performance:** UK operations continue to weigh on margins, while Hofmann Ceramics and Sheffield Refractories show early signs of recovery. --- # 3. Product & Segment Performance ## A. Key Figures * **Flow Control Refractories Revenue Mix:** **50–55%** of consolidated revenue * **TRM Model Revenue Contribution:** **35–40%** of total monthly revenue * **Snorkel Product Performance:** **85–119 heats** achieved vs. industry average of 65–80 * **Tundish Capacity Expansion:** Increased from **30 to 70 metric tons** with in-house tube changers * Stainless Steel Production Outlook: Projected rise from 4 million to 6 million tons in 1.5–2 years ## B. Flow Control Refractories * **Strategic Pivot in Europe:** Shift from application equipment to core refractory products is yielding positive revenue momentum. * **Domestic Expansion & Innovation:** Focused R&D-driven strategy has deepened relationships with leading steel producers and broadened customer reach. * **New Market Entry:** IFGL advancing into iron-making refractories, targeting growing demand from steel expansion projects. * **Customer Engagement:** In advanced talks with **2–3 major steel producers** for iron-making segment contracts. * **Growth Phasing:** Initial focus on stainless steel, with normal steel adoption expected within **2–3 years** pending quality validation. * **EAF Refractory Advantage:** Electric arc furnaces offer **5–3% higher refractory consumption** than conventional routes, creating incremental demand tailwinds. ## C. TRM Model Adoption * **TRM Gaining Traction:** Total Refractories Management model is becoming a strategic differentiator, enabling end-to-end solutions and deeper integration. * **Recurring Revenue Engine:** TRM drives predictable, long-term revenue streams and enhances operational visibility across customer plants. * **Market Positioning Goal:** TRM ambitions to elevate IFGL into the **top three** refractory suppliers industry-wide. * **Future Incentive Potential:** Performance-linked incentives under discussion for TRM contracts, though not yet finalized. * **Non-Ferrous Growth Pathway:** Emerging traction in non-ferrous segment signals diversification potential beyond steel and cement. * **UK Drag:** Monocon UK remains underperforming, weighing on profitability; turnaround efforts underway. ## D. Dolomite & Snorkel Products * **Snorkel Outperformance:** Products exceed industry benchmarks by **delivering 85–119 heats**, reducing downtime and consumption. * **In-House Tube Changer Impact:** New systems enable longer casting sequences and have **doubled tundish capacity**, boosting plant efficiency. * **Product Launch:** SIB-HSD1 mechanism launched for high-quality steelmaking, featuring precision engineering and enhanced safety. * **Dolomite Demand Drivers:** Adoption driven by **cleaner steel output**, with growth fueled by rising stainless production and import substitution. --- # 4. Capacity & Capex Projects ## A. Key Figures * **Capex Estimate:** **₹325 Cr** Khurda project · **₹300 Cr** Marvel JV facility * **Margin Guidance:** **8–10 pct pts higher** EBITDA margins at Khurda vs. current portfolio ## B. Khurda Expansion * **Strategic Greenfield Buildout:** Khurda expansion in Odisha progressing on track for **end-FY28 completion**, representing a 100% IFGL-owned, high-return capacity addition. * **High-Margin Growth Levers:** New capacities in Odisha and Gujarat expected to deliver **double-digit EBITDA margins** due to favorable product mix and **limited competition**, enhancing group profitability. ## C. Marvel JV Progress * **Gujarat JV Facility Advancing:** Second Gujarat plant via 51:49 Marvel JV moving forward with land fully acquired; execution supported by improved India-China business connectivity. * **Capital-Efficient Expansion:** Marvel JV structure enables strategic de-risking and shared investment burden while securing access to advanced manufacturing footprint. ## D. Technology Transfer * **Sheffield Integration on Revised Timeline:** Technology transfer delayed to **March–April 2026** due to key component supply issues; full operationalization expected by **end-Q1 next year**. * **Commercial Upside Ahead:** Localization of Sheffield technology to unlock **incremental revenue and margin uplift**, with new solutions already gaining traction ahead of contract renewals in **H1 calendar year**. --- # 5. Operational Efficiency ## A. Key Figures * **Standalone Employee Cost:** **₹35 Cr** (vs. expected ₹27 Cr at 10% of revenue) ## B. Cost Rationalization * **Margin Recovery Path:** Management has initiated targeted cost optimization to drive **gradual margin improvement** in coming quarters, particularly from underperforming Monocon segment. * **Monocon Turnaround Plan:** Actions include operational efficiency upgrades, cost-cutting, and sales recovery, with goal to **eliminate losses within a couple of quarters** and boost consolidated EBITDA margins. * **Headwinds Subsiding:** Q3 profitability pressure from higher overheads, lower exports, and business development investments is expected to ease as rationalization takes effect. ## C. Employee Cost Trends * **Cost Normalization Expected:** Elevated standalone employee costs (₹35 Cr) included **non-recurring expenses**, with reduction anticipated in Q4 and stabilization at **10% of sales**. * **Consolidated Discipline:** Consolidated employee costs to remain flat in **17–18% range**, with no structural increase expected despite current one-off items. * **Recurring vs. Non-Recurring:** Performance bonuses are contractually embedded and recurring; recent spikes driven by **one-time, non-repetitive charges** not expected to repeat. ## D. Margin Improvement Plan * **Mix-Driven Margin Pressure:** Gross and EBITDA margins softened due to **unfavorable product/sales mix** and elevated costs, though improvement is expected next quarter as mix normalizes. * **TRM Model Advantage:** On-site TRM operations deliver **superior profitability** versus direct material sales, with margins linked to application efficiency at customer sites. --- # 6. Risks & Market Conditions ## A. Key Figures * **Global Steel Demand:** **Flat** near-term · **Modest recovery in 2026** * **China Steel Demand:** **↓ ~2% in 2025** · Slower decline expected in 2026 * **Alumina Prices:** **Flattened but elevated**, maintaining cost pressure ## B. Europe Demand Pressure * **Persistent Profitability Drag:** UK operations face continued margin pressure from **slower-than-expected product adoption** in Europe, despite successful innovation and roadmap execution. * **Strategic Resilience:** Sheffield Refractory (UK) remains on track with strategic priorities, but market uptake lags, weighing on group profitability. ## C. Input Cost Volatility * **Cautious Optimism on Inflation:** Management believes the worst of **inflationary pressures, adverse mix, and high employee costs** is behind, enabling potential margin recovery. * **Sustained Competitive Edge:** Company maintains differentiation via **proven Sheffield Refractories technology**, even amid broad market competition. ## D. Regulatory Delays * **PN3-Driven JV Delays:** Joint venture progress hindered by **Press Note 3**, requiring additional approvals for tech transfers from border-sharing nations. * **Positive Policy Signals:** Resumption of **direct flights** and approval of a **special business visa** for tech transfer indicate improving bilateral conditions. --- # 7. Guidance & Outlook ## A. Key Figures * **Capex Plan:** **₹350 Cr** combined spend (60–70% in FY26, balance FY27) ## B. FY27 Revenue View * **Breakeven Target in Europe:** Expects to reach breakeven in Europe in FY27, contingent on stable macro conditions and operational improvements. * **Growth Strategy:** Focused on expanding domestic and international footprint, improving operational efficiencies, and increasing value-added product mix. * **No Near-Term Growth Guidance:** US revenue growth sustainability (37% in prior period) not confirmed; formal FY27 guidance to be provided next quarter. * **Business Platform Strengthening:** Building scalable, resilient foundation through advanced solution adoption and deeper customer relationships. ## C. Capex Spending Plan * **Phased Execution:** Majority of ₹350 Cr capex allocated to FY26, with remainder in FY27, ensuring disciplined capital deployment. * **Marvel Project Timing:** Spending commences in FY27 post-regulatory approval, aligned with 50%-50% debt-equity financing model. ## D. Profitability Targets * **Margin Pressure Persists:** Consolidated EBITDA margin tracking below prior guidance of **~12%** in 9M, weighed by cost headwinds. * **Path to Profitability:** Structural changes underway in UK operations, with expectation of **improved profitability in coming quarters**.